Current Cardiology Reviews · 2017 · 43 citations · 93 references
PharmacyBioengineeringBiomedical EngineeringBiocompatibilityBiomaterialsDrug DeliveryAntiplatelet TherapyCardiovascular BiomaterialsPolymeric BiomaterialsThrombosis PreventionAntiproliferative AgentsBioabsorbable PolymersBiodegradable Polymer CoatingsDrug-eluting CoatingsHypersensitivity ReductionPolymer CoatingsRestenosis After StentingStent Biomaterials
Drug-eluting stents (DES) have been shown to significantly reduce clinical and angiographic restenosis compared to bare metal stents (BMS). The polymer coatings on DES elute antiproliferative drugs to inhibit intimal proliferation and prevent restenosis after stent implantation. Permanent polymers which do not degrade in vivo may increase the likelihood of stent-related delayed arterial healing or polymer hypersensitivity. In turn, these limitations may contribute to an increased risk of late clinical events. Intuitively, a polymer which degrades after completion of drug release, leaving an inert metal scaffold in place, may improve arterial healing by removing a chronic source of inflammation, neoatherosclerosis, and/or late thrombosis. In this way, a biodegradable polymer may reduce late ischemic events. Additionally, improved healing after stent implantation could reduce the requirement for long-term dual antiplatelet therapy and the associated risk of bleeding and cost. This review will focus on bioabsorbable polymer-coated DES currently being evaluated in clinical trials.
93
Patrick W. Serruys, Peter de Jaegere, Ferdinand Kiemeneij et al. · New England Journal of Medicine · 1994 · 4.5K citations · Full text
Pathology of Drug-Eluting Stents in Humans
Michael Joner, Aloke V. Finn, Andrew Farb et al. · Journal of the American College of Cardiology · 2006 · 2.7K citations
Medicine, Cardiology, Pathology +11
Guidelines for the Primary Prevention of Stroke
James F. Meschia, Cheryl Bushnell, Lynne T. Braun et al. · Stroke · 2014 · 2.7K citations · Full text
Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
Laura Mauri, Robert W. Yeh, Priscilla Driscoll-Shempp et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text
Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent
Renu Virmani, Giulio Guagliumi, Andrew Farb et al. · Circulation · 2004 · 1.5K citations · Full text
Medicine, Cardiology, Immunology +13